Skip to content
ppharmaranks
Menu

ATZUMI vs EMGALITY

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. ATZUMI and EMGALITY are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

New
New

Pharmacy pays

$34.84 /mL

Type

RX
RX

Active ingredient

DIHYDROERGOTAMINE MESYLATE
GALCANEZUMAB-GNLM

Dosage forms

Powder
Injectable

Drug class

Ergotamine Derivative

Boxed warning

Half-life

about 9 to 13 hours, depending on the form

Treats

Cluster Headache, Postpartum Hemorrhage, Orthostatic Hypotension
Cluster Headache

Get atzumihigher-rated option

Advertising disclosure: Some links are affiliate links. We may earn a commission at no extra cost to you. This never affects our independent ratings.

Get treatment online

Licensed online providers — consult & get prescribed if eligible.

Frequently asked questions

What is the difference between Atzumi and Emgality?

Atzumi contains Dihydroergotamine Mesylate, while Emgality contains Galcanezumab-Gnlm — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.